GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Other Gross PPE

Zelira Therapeutics (ASX:ZLD) Other Gross PPE : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2003. Start your Free Trial

What is Zelira Therapeutics Other Gross PPE?

Zelira Therapeutics's Other Gross PPE for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Zelira Therapeutics's quarterly Other Gross PPE increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.75 Mil) but then declined from Jun. 2023 (A$0.75 Mil) to Dec. 2023 (A$0.00 Mil).

Zelira Therapeutics's annual Other Gross PPE increased from Jun. 2021 (A$0.63 Mil) to Jun. 2022 (A$0.65 Mil) and increased from Jun. 2022 (A$0.65 Mil) to Jun. 2023 (A$0.75 Mil).


Zelira Therapeutics Other Gross PPE Historical Data

The historical data trend for Zelira Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelira Therapeutics Other Gross PPE Chart

Zelira Therapeutics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.64 0.63 0.65 0.75

Zelira Therapeutics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.65 - 0.75 -

Zelira Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Zelira Therapeutics (ASX:ZLD) Business Description

Traded in Other Exchanges
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Zelira Therapeutics (ASX:ZLD) Headlines

No Headlines